According to the Wall Street Journal, McKesson Corporation (NYSE: MCK) is in final stage of talks with Franz Haniel & Cie to acquire its drug distribution unit, Celesio, in a deal worth more than $ 5 billion. Founded in 1835, Stuttgart based Celesio supplies drugs to 65,000 pharmacies and hospitals, daily with nearly 130,000 pharmaceutical products. McKesson has offered about 22 euro per share, which translates in to 3.74 billion euro ($ 5.08 billion), a premium of 30% over the stock’s most recent closing price.
Recent Comments